A Pharmacodynamic Pre-surgical Study of Hedgehog Pathway Inhibition With LDE225 in Men With High-risk Localized Prostate Cancer.
Phase of Trial: Phase I
Latest Information Update: 09 Mar 2019
Price : $35 *
At a glance
- Drugs Sonidegib (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 26 Apr 2017 Status changed from recruiting to completed.
- 05 Mar 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.